Published in Lancet on July 01, 1972
Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol (1996) 72.84
Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res (2001) 9.62
Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science (1985) 8.72
Genomic analysis of gene expression in C. elegans. Science (2000) 8.38
Computer simulation of industrial hazards. Br J Ind Med (1973) 6.36
High-pressure liquid chromatography in polynucleotide synthesis. Biochemistry (1978) 5.98
Evaluation of normalization procedures for oligonucleotide array data based on spiked cRNA controls. Genome Biol (2001) 5.61
Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J Bacteriol (2001) 5.57
Ages and frequencies for cervical cancer screening. Br J Cancer (1976) 4.14
A cohort study of cervical cancer screening in British Columbia. Clin Invest Med (1982) 3.80
Epidural anaesthesia and long term backache after childbirth. BMJ (1990) 3.61
An investigation into the purposes, accuracy, and effective uses of the Blind Register in England. Br J Prev Soc Med (1973) 3.56
The quality of notification of congenital malformations. J Epidemiol Community Health (1984) 3.31
The thermal stability of oligonucleotide duplexes is sequence independent in tetraalkylammonium salt solutions: application to identifying recombinant DNA clones. Nucleic Acids Res (1988) 2.95
Investigation of long term problems after obstetric epidural anaesthesia. BMJ (1992) 2.89
Decorin-binding adhesins from Borrelia burgdorferi. Mol Microbiol (1998) 2.85
Strategy for rubella vaccination. Int J Epidemiol (1980) 2.74
Confidential medical records and epidemiological research. BMJ (1992) 2.66
Leukaemia clusters in childhood: geographical analysis in Britain. J Epidemiol Community Health (1994) 2.53
Ischaemic-heart-disease mortality and dietary intake of calcium. Lancet (1973) 2.46
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc Natl Acad Sci U S A (1999) 2.44
Planning medical information systems in a unified health service. Lancet (1972) 2.31
Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature (1985) 2.25
Anencephalus and dietary intakes. Br J Prev Soc Med (1972) 2.17
Human T-cell growth factor: partial amino acid sequence, cDNA cloning, and organization and expression in normal and leukemic cells. Proc Natl Acad Sci U S A (1984) 2.12
Twins and neural tube defects. Br J Prev Soc Med (1974) 2.01
Fetus-fetus interaction--a model aetiology for anencephalus. Dev Med Child Neurol (1970) 2.00
Smoking in pregnancy: effects of stopping at different stages. Br J Obstet Gynaecol (1988) 1.78
Foetal-maternal transfusion and rhesus sensitization. J Obstet Gynaecol Br Commonw (1966) 1.77
Substituting an alpha-helix switches the sequence-specific DNA interactions of a repressor. Cell (1984) 1.63
Chemical synthesis and cloning of a tyrosine tRNA gene. Methods Enzymol (1979) 1.63
Immobilization of DNA via oligonucleotides containing an aldehyde or carboxylic acid group at the 5' terminus. Nucleic Acids Res (1987) 1.55
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements. J Med Chem (1999) 1.55
Leukaemia and childhood cancer in twins. J Epidemiol Community Health (1984) 1.52
Principles of allocation of health care resources. J Epidemiol Community Health (1978) 1.51
The organisation of breast-cancer services. Lancet (1976) 1.51
Changing incidence of infantile hypertrophic pyloric stenosis. Arch Dis Child (1983) 1.45
A case of respiratory failure complicated by acute hypophosphataemia. Anaesthesia (1980) 1.36
Total synthesis of a tyrosine suppressor transfer RNA gene. XVI. Enzymatic joinings to form the total 207-base pair-long DNA. J Biol Chem (1979) 1.33
Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides. J Exp Med (1991) 1.27
Obstetric determinants of rhesus sensitisation. Lancet (1968) 1.26
Effect of anti-smoking health education on infant size at birth: a randomized controlled trial. Br J Obstet Gynaecol (1987) 1.25
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements. J Med Chem (1998) 1.24
Birth dates of men with cancer of the testis. J Epidemiol Community Health (1985) 1.23
Epidemics of rare diseases. Br Med Bull (1971) 1.20
Perinatal mortality standards: construction and use of a health care performance indicator. J Epidemiol Community Health (1986) 1.19
Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease. J Med Chem (1996) 1.19
The t-unique coding domain is important to the transformation maintenance function of the simian virus 40 small t antigen. Mol Cell Biol (1986) 1.16
The incidence of cataract and its clinical presentation. Community Health (Bristol) (1975) 1.16
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies. J Med Chem (1998) 1.14
A transmission model for AIDS. Eur J Epidemiol (1986) 1.14
Disease concordance and sex similarity in twins. J Epidemiol Community Health (1980) 1.13
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies. J Med Chem (1998) 1.12
Theoretical aspects of rubella vaccination strategies. Rev Infect Dis (1985) 1.11
Multiphasic screening. Lancet (1974) 1.11
Childhood cancers: space-time distribution in Britain. J Epidemiol Community Health (1995) 1.10
Health after childbirth. Br J Obstet Gynaecol (1991) 1.10
Solution structure and peptide binding of the SH3 domain from human Fyn. Structure (1996) 1.08
A synthetic tyrosine suppressor tRNA gene with an altered promoter sequence. Its cloning and relative expression in vivo. J Biol Chem (1979) 1.08
Accidental dural puncture in obstetric patients and long term symptoms. BMJ (1993) 1.07
Standardized perinatal mortality ratios: technique, utility and interpretation. Community Med (1979) 1.07
Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci U S A (1993) 1.07
The synthesis and cloning of two tyrosine suppressor tRNA genes with altered promoter sequences. J Biol Chem (1981) 1.06
Geographical distribution of birth places of children with cancer in the UK. Br J Cancer (1998) 1.04
Transcriptional profiling of human osteoblast differentiation. J Cell Biochem (2003) 1.04
Foods and diseases. Br J Prev Soc Med (1977) 1.02
Effects at age nine of maternal smoking in pregnancy: experimental and observational findings. BJOG (2001) 0.98
Social and health care determinants of area variations in perinatal mortality. Community Med (1980) 0.98
Negligible risks to health. Community Health (Bristol) (1975) 0.98
A working population model for haemolytic disease of the newborn. Arch Dis Child (1968) 0.96
Spina bifida in Birmingham. Dev Med Child Neurol (1967) 0.94
Approaches to the release of a master cell bank of PER.C6 cells; a novel cell substrate for the manufacture of human vaccines. Dev Biol (Basel) (2006) 0.93
Detection of minimal epidemics. Stat Med (1983) 0.93
Total synthesis of a tyrosine suppressor tRNA gene. XVIII. Biological activity and transcription, in vitro, of the cloned gene. J Biol Chem (1979) 0.93
Quantitative estimation of bilirubin in liquor amnii. Lancet (1966) 0.93
Epidemiology of prenatal infections: an extension of the congenital rubella model. Stat Med (1984) 0.92
Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J Clin Invest (1989) 0.92
Childhood leukaemia and mother-foetus infection. Br J Cancer (1980) 0.92
Passive smoking and birthweight. Lancet (1987) 0.91
Inflight measurement of pilot workload: a panel discussion. Aviat Space Environ Med (1978) 0.91
Meteorological associations of cerebrovascular disease mortality in England and Wales. J Epidemiol Community Health (1981) 0.89
Executive Council lists and general practitioner files. Br J Prev Soc Med (1974) 0.88
Psycho-maintenance in asthma: hospitalization rates and financial impact. Br J Med Psychol (1980) 0.88
Cancer following nuclear weapons tests. Lancet (1983) 0.86
Specific Th1 cell lines that confer protective immunity against experimental Borrelia burgdorferi infection in mice. J Leukoc Biol (1998) 0.85
Selective and opposing actions of progesterone receptor isoforms in human endometrial stromal cells. Mol Cell Endocrinol (2006) 0.85
Epidemiological approach to Parkinson's disease. Lancet (1972) 0.85
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors. Bioorg Med Chem Lett (2000) 0.84
The nurse must know... the nurse must speak. Nurs Forum (1966) 0.84
Case clustering in pityriasis rosea: support for role of an infective agent. Br Med J (Clin Res Ed) (1982) 0.83
Perinatal mortality: effectiveness of selective interventions. Lancet (1979) 0.83
The relation between gap discrimination and auditory stream segregation. Percept Psychophys (1982) 0.83
The epidemiology of Parkinson's disease. Proc R Soc Med (1973) 0.82
Evaluation of 'infant at risk' registers. Arch Dis Child (1970) 0.81
Alexithymic asthmatics: the miscommunication of affective and somatic states. Psychother Psychosom (1981) 0.81
Histoplasmosis. Can Med Assoc J (1956) 0.81
Control of haemolytic disease of the newborn. Br J Prev Soc Med (1976) 0.81
Topical lignocaine in poor-risk cases. Br J Anaesth (1978) 0.80
Total synthesis of a tyrosine suppressor transfer RNA gene. XIV. Chemical synthesis of oligonucleotide segments corresponding to the terminal regions. J Biol Chem (1979) 0.80